MBX Biosciences, Inc. (MBX)
31.66
+0.94
(+3.06%)
USD |
NASDAQ |
Jan 09, 16:00
31.64
-0.02
(-0.06%)
After-Hours: 20:00
MBX Biosciences EPS Diluted (Quarterly): -0.6321 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Insmed, Inc. | -1.747 |
| ARS Pharmaceuticals, Inc. | -0.5177 |
| Aardvark Therapeutics, Inc. | -0.7503 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.62M |
| Total Expenses (Quarterly) | 21.62M |
| Enterprise Value | 672.54M |
| Earnings Yield | -7.56% |
| Normalized Earnings Yield | -7.56 |